CDKN2A and Alzheimer disease: Similarly, elevated expression of the cyclin‐dependent kinase inhibitor 2a, Cdkn2a, is one of the most robust markers of cellular senescence, and its protein product, p16INK4A, colocalizes with NFTs in human AD (Arendt et al., 1996).